| Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce F Rahman, V Bhat, A Ozair, DKE Detchou, MS Ahluwalia Medical Education Online 29 (1), 2302232, 2024 | | 2024 |
| A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR) MS Ahluwalia, A Ozair, M Rudek, X Ye, M Holdhoff, FS Lieberman, ... Cell Reports Medicine, 2024 | | 2024 |
| Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT MS Ahluwalia, A Ozair, J Drappatz, X Ye, S Peng, M Lee, S Rath, H Dhruv, ... Clinical Cancer Research, 2024 | | 2024 |
| Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis T Kutuk, Y Zhang, EY Akdemir, S Yarlagadda, R Tolakanahalli, MD Hall, ... Journal of Neuro-Oncology, 1-13, 2024 | | 2024 |
| Prevention of Brain Metastases: A New Frontier A Pellerino, TM Davidson, SS Bellur, MS Ahluwalia, H Tawbi, R Rudà, ... Cancers 16 (11), 2134, 2024 | | 2024 |
| HGG-40. UNRAVELING THE IMMUNOLOGIC VULNERABILITIES OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT RT Galvin, N Sadeghipour, J Xiu, DM Ashley, MS Ahluwalia, S Aulakh, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| Unraveling the immunologic vulnerabilities of diffuse hemispheric glioma, H3 G34-mutant. RT Galvin, N Sadeghipour, J Xiu, DM Ashley, MS Ahluwalia, S Aulakh, ... Journal of Clinical Oncology 42 (16_suppl), 2082-2082, 2024 | | 2024 |
| The role of the ubiquitin ligase UBE4B in neural tumors in adults and children. PE Zage, C Le Clorennec, TT Adeyelu, J Xiu, S Aulakh, ES Antonarakis, ... Journal of Clinical Oncology 42 (16_suppl), e14034-e14034, 2024 | | 2024 |
| Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC … MP Mehta, V Gondi, MS Ahluwalia, D Roberge, R Ilic, TTW Sio, ... Journal of Clinical Oncology 42 (16_suppl), 2008-2008, 2024 | | 2024 |
| Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis. V Podder, MA Ganiyani, S Ahmad, SS Bellur, MA Khokhar, FS Ayoobkhan, ... Journal of Clinical Oncology 42 (16_suppl), 4561-4561, 2024 | | 2024 |
| Dual-agent immunotherapy for prevention of melanoma brain metastases: A real-world analysis of 8686 patients. A Mansouri, D Bhanja, HE Wilding, N Mikolajewicz, A Ozair, ... Journal of Clinical Oncology 42 (16_suppl), 2022-2022, 2024 | | 2024 |
| Implications of HPV infection on survival outcomes in patients with penile squamous cell carcinoma: Insights from a nationwide study. R Garje, MA Ganiyani, AA Khosla, S Ahmad, V Podder, SS Bellur, ... Journal of Clinical Oncology 42 (16_suppl), 5045-5045, 2024 | | 2024 |
| Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan. V Podder, T Ranjan, M Bardhan, A McCracken, C Hurmiz, MA Ganiyani, ... Journal of Clinical Oncology 42 (16_suppl), 1036-1036, 2024 | | 2024 |
| Socioeconomic disparities in survival outcomes of patients with NSCLC with brain metastases: A real-world analysis. SS Bellur, S Ahmad, V Bhat, MA Ganiyani, A Ozair, D Jayram, AA Khosla, ... Journal of Clinical Oncology 42 (16_suppl), 8569-8569, 2024 | | 2024 |
| Survival outcomes in patients with advanced intrahepatic cholangiocarcinoma in United States: A nationwide analysis. D Jayram, N Aziz, H Naeem, S Ahmad, MAH Chaudhary, SS Bellur, ... Journal of Clinical Oncology 42 (16_suppl), e16211-e16211, 2024 | | 2024 |
| Co-occurrence of ESR1 and PIK3CA mutations in HR+/HER2- metastatic breast cancer: Incidence and outcomes with targeted therapy. N Dempsey, P Bhatt, C Lewis, D Tolman, Y Chamorro, M Rubens, ... Journal of Clinical Oncology 42 (16_suppl), e13097-e13097, 2024 | | 2024 |
| Socioeconomic disparities in survival outcomes of patients with SCLC with brain metastases: A nationwide analysis. SS Bellur, D Jayram, S Ahmad, V Bhat, A Ozair, MA Ganiyani, AA Khosla, ... Journal of Clinical Oncology 42 (16_suppl), e20133-e20133, 2024 | | 2024 |
| Phase 1 study of BDTX-1535, an oral 4th generation covalent EGFR inhibitor, in patients with recurrent glioblastoma: Preliminary dose escalation results. PY Wen, ML Johnson, JT Henry, A Spira, J Battiste, I Alnahhas, DH Nam, ... Journal of Clinical Oncology 42 (16_suppl), 2068-2068, 2024 | | 2024 |
| Examining global and gender disparities in high-impact evidence synthesis on lung cancer: A 2000-2024 analysis of Cochrane Library. V Bhat, SS Bellur, A Kumar, S Kaushik, A Ozair, HK Walia, MS Ahluwalia Journal of Clinical Oncology 42 (16_suppl), e23021-e23021, 2024 | | 2024 |
| Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients … LA Huppert, RL Mahtani, SC Fisch, N Dempsey, S Premji, A Taylor, ... Journal of Clinical Oncology 42 (16_suppl), 1083-1083, 2024 | 3 | 2024 |
Samuel ChaoAssociate Professor, Cleveland Clinic Lerner College of Medicine在 ccf.org 的电子邮件经过验证
